Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bicycle Therapeutics Ltd

BCYC
Current price
8.73 USD +1.12 USD (+14.72%)
Last closed 6.75 USD
ISIN US0887861088
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 511 405 728 USD
Yield for 12 month -61.49 %
1Y
3Y
5Y
10Y
15Y
BCYC
21.11.2021 - 28.11.2021

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase I/II/III clinical trials for the treatment of high nectin-4 expressing tumors; BT5528 (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; and BT7480, a Bicycle tumor-targeted immune cell agonist molecule, which is in phase I/II targeting nectin-4 and agonizing CD137. In addition, it develops Novel CNS targets, which is in preclinical trial targeting CNS disease; Novel neuromuscular targets, which is in preclinical trial targeting neuromuscular disease; and programs that is in preclinical trial targeting radiopharmaceutical. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas. It has collaboration and license agreement with Bayer Consumer Care AG; Novartis Pharma AG; Ionis Pharmaceuticals, Inc.; and Genentech, Inc. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom. Address: Portway Building, Cambridge, United Kingdom, CB21 6GS

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

27.70 USD

P/E ratio

Dividend Yield

Current Year

+35 275 000 USD

Last Year

+26 976 000 USD

Current Quarter

+3 708 000 USD

Last Quarter

+2 676 000 USD

Current Year

+35 275 000 USD

Last Year

+20 509 188 USD

Current Quarter

+3 708 000 USD

Last Quarter

+481 724 USD

Key Figures BCYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -202 698 000 USD
Operating Margin TTM -1 824.78 %
Price to Earnings
Return On Assets TTM -16.90 %
PEG Ratio
Return On Equity TTM -29.04 %
Wall Street Target Price 27.70 USD
Revenue TTM 35 275 000 USD
Book Value 11.48 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -30.40 %
Dividend Yield
Gross Profit TTM -137 691 008 USD
Earnings per share -2.90 USD
Diluted Eps TTM -2.90 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BCYC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History BCYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation BCYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 21.22
Price Sales TTM 14.50
Enterprise Value EBITDA -2.14
Price Book MRQ 0.64

Financials BCYC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BCYC

For 52 weeks

6.10 USD 28.67 USD
50 Day MA 9.71 USD
Shares Short Prior Month 4 400 372
200 Day MA 18.14 USD
Short Ratio 12.75
Shares Short 4 304 866
Short Percent 9.73 %